menu
    • menu

    Company profile for Crossbow Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target th...
    Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crossbow TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1030 Massachusetts Ave. Suite 210 Cambridge, MA 02138
    Telephone
    Telephone
    +1 8577569164
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.crossbowtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crossbow-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crossbow Therapeutics Doses 1st Patient in Ph 1 Trial of CBX-250
    Crossbow Therapeutics Doses 1st Patient in Ph 1 Trial of CBX-250

    16 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-16/crossbow-therapeutics-doses-first-patient-in-phase-1-trial-of-cbx-250-for-myeloid-malignancies

    PHARMAWEB
    16 Sep 2025
    Share Share
    Crossbow Picks CBX-663 for Solid and Blood Cancer Treatment
    Crossbow Picks CBX-663 for Solid and Blood Cancer Treatment

    23 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250723684640/en/Crossbow-Therapeutics-Nominates-its-Second-Development-Candidate-CBX-663-a-Broadly-Acting-Therapeutic-for-a-Wide-Range-of-Solid-and-Hematologic-Malignancies

    BUSINESSWIRE
    23 Jul 2025
    Share Share
    Crossbow Selects First Development Candidate from its T-cell Engagers
    Crossbow Selects First Development Candidate from its T-cell Engagers

    05 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/05/2840984/0/en/Crossbow-Therapeutics-Selects-First-Development-Candidate-from-its-Portfolio-of-Next-Generation-T-cell-Engagers-Directed-at-Intracellular-Cancer-Targets.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    Crossbow Therapeutics Launches with $80 Million in Series A Financing
    Crossbow Therapeutics Launches with $80 Million in Series A Financing

    11 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/11/2702519/0/en/Crossbow-Therapeutics-Launches-with-80-Million-in-Series-A-Financing-to-Advance-a-Novel-Class-of-Antibody-Therapies-That-Mimic-T-Cell-Receptors-to-Treat-Cancer.html

    GLOBENEWSWIRE
    11 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search